Federation des caisses Desjardins du Quebec Boosts Stake in GE HealthCare Technologies Inc. $GEHC

Federation des caisses Desjardins du Quebec increased its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 20.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,241 shares of the company's stock after purchasing an additional 3,456 shares during the quarter. Federation des caisses Desjardins du Quebec's holdings in GE HealthCare Technologies were worth $1,634,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently modified their holdings of the company. Ameriprise Financial Inc. boosted its position in GE HealthCare Technologies by 38.9% during the 4th quarter. Ameriprise Financial Inc. now owns 515,985 shares of the company's stock valued at $40,337,000 after acquiring an additional 144,495 shares in the last quarter. Benjamin Edwards Inc. boosted its position in GE HealthCare Technologies by 19.5% during the 4th quarter. Benjamin Edwards Inc. now owns 4,632 shares of the company's stock valued at $362,000 after acquiring an additional 757 shares in the last quarter. Captrust Financial Advisors boosted its position in GE HealthCare Technologies by 8.6% during the 4th quarter. Captrust Financial Advisors now owns 36,214 shares of the company's stock valued at $2,831,000 after acquiring an additional 2,861 shares in the last quarter. BOKF NA boosted its position in GE HealthCare Technologies by 11.0% during the 4th quarter. BOKF NA now owns 1,742 shares of the company's stock valued at $148,000 after acquiring an additional 173 shares in the last quarter. Finally, Cetera Investment Advisers boosted its position in GE HealthCare Technologies by 2.9% during the 4th quarter. Cetera Investment Advisers now owns 79,544 shares of the company's stock valued at $6,219,000 after acquiring an additional 2,244 shares in the last quarter. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Stock Performance

GEHC traded down $1.08 during mid-day trading on Friday, reaching $76.88. 1,637,261 shares of the company traded hands, compared to its average volume of 3,951,088. The stock has a market capitalization of $35.10 billion, a P/E ratio of 15.77, a P/E/G ratio of 2.90 and a beta of 1.13. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85. The company's fifty day moving average price is $74.45 and its 200-day moving average price is $73.76. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, beating analysts' consensus estimates of $0.91 by $0.15. The business had revenue of $5 billion during the quarter, compared to analyst estimates of $4.96 billion. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The company's quarterly revenue was up 3.5% compared to the same quarter last year. During the same period in the previous year, the business earned $1.00 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 25th were paid a dividend of $0.035 per share. The ex-dividend date was Friday, July 25th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies's payout ratio is currently 2.87%.

Analyst Upgrades and Downgrades

Several research firms have weighed in on GEHC. Zacks Research raised GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a research report on Thursday, August 28th. Morgan Stanley lowered their target price on shares of GE HealthCare Technologies from $78.00 to $74.00 and set an "equal weight" rating for the company in a report on Thursday, July 31st. Wall Street Zen upgraded shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating in a report on Saturday, May 31st. Citigroup lifted their target price on shares of GE HealthCare Technologies from $89.00 to $93.00 and gave the company a "buy" rating in a report on Thursday, July 31st. Finally, BTIG Research reiterated a "buy" rating on shares of GE HealthCare Technologies in a report on Monday, July 14th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $88.40.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.